These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

608 related items for PubMed ID: 25887296

  • 1. (5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway.
    Shen Y, Jiang T, Wang R, He S, Guo M, Zuo J, He D.
    BMC Complement Altern Med; 2015 Mar 24; 15():77. PubMed ID: 25887296
    [Abstract] [Full Text] [Related]

  • 2. Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor kappaB, osteoprotegerin, and receptor activator of nuclear factor kappaB ligand.
    Lee CK, Lee EY, Chung SM, Mun SH, Yoo B, Moon HB.
    Arthritis Rheum; 2004 Dec 24; 50(12):3831-43. PubMed ID: 15593184
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling.
    Kalliolias GD, Zhao B, Triantafyllopoulou A, Park-Min KH, Ivashkiv LB.
    Arthritis Rheum; 2010 Feb 24; 62(2):402-13. PubMed ID: 20112358
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Interleukin-20 differentially regulates bone mesenchymal stem cell activities in RANKL-induced osteoclastogenesis through the OPG/RANKL/RANK axis and the NF-κB, MAPK and AKT signalling pathways.
    Meng B, Wu D, Cheng Y, Huang P, Liu Y, Gan L, Liu C, Cao Y.
    Scand J Immunol; 2020 May 24; 91(5):e12874. PubMed ID: 32090353
    [Abstract] [Full Text] [Related]

  • 8. Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha.
    Dai SM, Nishioka K, Yudoh K.
    Ann Rheum Dis; 2004 Nov 24; 63(11):1379-86. PubMed ID: 15479886
    [Abstract] [Full Text] [Related]

  • 9. Regulation of OPG and RANKL expressed by human dental follicle cells in osteoclastogenesis.
    Sun H, Li Q, Zhang Y, Bi Y, Li X, Shu Y, Chen X, Jin Z, Ge C.
    Cell Tissue Res; 2015 Nov 24; 362(2):399-405. PubMed ID: 26149648
    [Abstract] [Full Text] [Related]

  • 10. Rheumatoid and pyrophosphate arthritis synovial fibroblasts induce osteoclastogenesis independently of RANKL, TNF and IL-6.
    Dickerson TJ, Suzuki E, Stanecki C, Shin HS, Qui H, Adamopoulos IE.
    J Autoimmun; 2012 Dec 24; 39(4):369-76. PubMed ID: 22867712
    [Abstract] [Full Text] [Related]

  • 11. Pioglitazone affects the OPG/RANKL/RANK system and increase osteoclastogenesis.
    Xu F, Dong Y, Huang X, Chen P, Guo F, Chen A, Huang S.
    Mol Med Rep; 2016 Sep 24; 14(3):2289-96. PubMed ID: 27430581
    [Abstract] [Full Text] [Related]

  • 12. Interleukin 29 inhibits RANKL-induced osteoclastogenesis via activation of JNK and STAT, and inhibition of NF-κB and NFATc1.
    Peng Q, Luo A, Zhou Z, Xuan W, Qiu M, Wu Q, Xu L, Kong X, Zhang M, Tan W, Xue M, Wang F.
    Cytokine; 2019 Jan 24; 113():144-154. PubMed ID: 30001863
    [Abstract] [Full Text] [Related]

  • 13. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
    Quinn JM, Horwood NJ, Elliott J, Gillespie MT, Martin TJ.
    J Bone Miner Res; 2000 Aug 24; 15(8):1459-66. PubMed ID: 10934644
    [Abstract] [Full Text] [Related]

  • 14. miR-145-5p Increases Osteoclast Numbers In Vitro and Aggravates Bone Erosion in Collagen-Induced Arthritis by Targeting Osteoprotegerin.
    Chen Y, Wang X, Yang M, Ruan W, Wei W, Gu D, Wang J, Guo X, Guo L, Yuan Y.
    Med Sci Monit; 2018 Jul 30; 24():5292-5300. PubMed ID: 30059491
    [Abstract] [Full Text] [Related]

  • 15. [Effect of Erigeron Breviscapus on the expression of OPG/RANKL/RANK in osteoblasts and pre-osteoclasts in vitro].
    Liu CG, Luo QX, Ling TY, Mo YY, Cheng ZL, Huang SG, Mo H.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Dec 30; 33(12):1658-64. PubMed ID: 24517065
    [Abstract] [Full Text] [Related]

  • 16. [Effect of Bushen Tongdu Capsule on RANK/RANKL/OPG pathway of collagen induced arthritis rats].
    Zhu YC, Lin L, Zhou XL, Li RF, Hou LP.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Dec 30; 34(12):1487-91. PubMed ID: 25632751
    [Abstract] [Full Text] [Related]

  • 17. Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts.
    Kim KW, Kim HR, Park JY, Park JS, Oh HJ, Woo YJ, Park MK, Cho ML, Lee SH.
    Arthritis Rheum; 2012 Apr 30; 64(4):1015-23. PubMed ID: 22034096
    [Abstract] [Full Text] [Related]

  • 18. Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis.
    Takayanagi H, Iizuka H, Juji T, Nakagawa T, Yamamoto A, Miyazaki T, Koshihara Y, Oda H, Nakamura K, Tanaka S.
    Arthritis Rheum; 2000 Feb 30; 43(2):259-69. PubMed ID: 10693864
    [Abstract] [Full Text] [Related]

  • 19. IL-6 signal blockade ameliorates the enhanced osteoclastogenesis and the associated joint destruction in a novel FcγRIIB-deficient rheumatoid arthritis mouse model.
    Ohtsuji M, Lin Q, Nishikawa K, Ohtsuji N, Okazaki H, Tsurui H, Amano H, Shirai T, Nishimoto N, Nishimura H, Hirose S.
    Mod Rheumatol; 2015 Mar 30; 25(2):270-7. PubMed ID: 25159156
    [Abstract] [Full Text] [Related]

  • 20. The abundant synovial expression of the RANK/RANKL/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation.
    Vandooren B, Cantaert T, Noordenbos T, Tak PP, Baeten D.
    Arthritis Rheum; 2008 Mar 30; 58(3):718-29. PubMed ID: 18311801
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.